Outcomes in pediatrics patients diagnosed with bone marrow failure disorders treated in a tertiary care center.

Introduction: Bone marrow failure (BMF) syndromes are rare disorders with an annual incidence of 2-4 cases per million. Treatment options include immunosuppressive therapy (IST) and hematopoietic stem cell transplantation (HSCT).

Objective: To analyze the outcomes of pediatric patients diagnosed with BMF treated in a tertiary care center.